JLGH Fall 2025 Recap
Q&A for Extended Learning
Q: What initial management options can primary care clinicians suggest for children and adolescents with primary headaches?
- Lifestyle modifications can include attention to sleep, hydration and nutrition, and activity levels, as well as behavioral health.
- Rescue medications might include ibuprofen or a triptan.
- Preventative approaches include cognitive behavioral therapy, dietary supplements, and preventative medications to help with sleep and appetite.
Q: Diagnosing thrombocytopenia in patients can be tricky, because there can be many different etiologies. Clinicians should consider whether the patient has experienced exposure to heparin or tick bites, as well as whether patients have adequate intake of vitamin B12. What diagnosis might an elevated PLASMIC score and an affirming ADAMS13 lab test help to establish?
A: Thrombotic thrombocytopenic purpura.
Q: How can clinicians distinguish cellulitis and an underlying abscess?
A: Symptoms of cellulitis include erythema, edema, warmth, and pain. A skin abscess is a collection of pus that is fluctuant, often with an erythematous nodule. Patients with cellulitis may or may not present with an abscess.
Read the article.
Q: What is FIB-4, and when should it be used?
A: The fibrosis-4 index is a non-invasive tool used to identify patients suspected to have metabolic dysfunction-associated steatotic liver disease who may advance to fibrosis. It should be used to screen patients with type 2 diabetes mellitus, obesity, and ≥1 cardiometabolic risk factor, or persistently elevated liver enzymes..
Read the article.
Q: What pharmacologic agents are approved by the Food and Drug Administration for the management of metabolic dysfunction-associated steatohepatitis in patients with type 2 diabetes mellitus?
A: Resmetirom and Wegovy® (semaglutide).
Read the article.
|